Last updated on February 2018

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy


Brief description of study

A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by maintenance therapy with DFMO in subjects with newly diagnosed high risk neuroblastoma.

Clinical Study Identifier: NCT02559778

Contact Investigators or Research Sites near you

Start Over

Kathleen Neville, MD

Arkansas Children's Hospital
Little Rock, AR United States
  Connect »

William Roberts, MD

Rady Children's Hospital
San Diego, CA United States
  Connect »

Michael Isakoff, MD

Connecticut Children's Hospital
Hartford, CT United States
  Connect »

Randal Wada, MD

Kapiolani Medical Center for Women and Children
Honolulu, HI United States
  Connect »

Giselle Sholler, MD

Helen DeVos Children's Hospital
Grand Rapids, MI United States
  Connect »

Jawhar Rawwas, MD

Children's Hospital and Clinics on Minnesota
Minneapolis, MN United States
  Connect »

William Ferguson, MD

Cardinal Glennon Children's Medical Center
Saint Louis, MO United States
  Connect »

Javier Oesterheld, MD

Levine Children's Hospital
Charlotte, NC United States
  Connect »

Valerie Brown, MD

Penn State Milton S. Hershey Medical Center and Children's Hospital
Hershey, PA United States
  Connect »

Jaqueline Kraveka, MD

Medical University of South Carolina
Charleston, SC United States
  Connect »

Virginia Harrod, MD

Dell Children's Blood and Cancer Center
Austin, TX United States
  Connect »

Ted Laetsch, MD

Children's Medical Center
Dallas, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.